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Abstract
Background: To prevent ovarian cancer, several international societies have issued guidelines which recommend
to discuss opportunistic salpingectomy with women undergoing pelvic surgery after completion of childbearing.
The opportunistic salpingectomy refers to the additional removal of Fallopian tubes during pelvic surgery for
another indication to reduce the risk of developing ovarian cancer. These recommendations emphasize the
importance of counselling on benefits and risks of opportunistic salpingectomy but offer no guidance on their
implementation in daily practice. The lack of a tailored implementation strategy has resulted in a wide variation in
current practice. To reduce this practice variation, we identified influencing factors on implementing opportunistic
salpingectomy from patients’ and professionals’ perspectives.
Methods: We conducted a mixed-method study between 2019 and 2020 throughout the Netherlands. In a
qualitative phase, we conducted interviews with gynecologic patients (N = 11) and their professionals (N = 20) to
explore barriers and facilitators, using an interview guide. In the quantitative phase, we quantified these barriers and
facilitators among patients who underwent a hysterectomy or sterilization and were counselled on the
opportunistic salpingectomy (N = 77), and members of the Dutch Society of Obstetrics and Gynecology (N = 204),
using questionnaires. For both phases, barriers and facilitators were classified into the following domains:
innovation, patient, healthcare professional, social setting, organization, and economic and political context.
Results: For patients, main barriers were lack of knowledge about: the existence of the opportunistic salpingectomy
(45%), size of the surgery (44%) and its associated possible disadvantages (37%). In addition, patients attributed their
reluctance to concerns about the removal of healthy organs (46%). For professionals, main barriers were: patients’
lack of knowledge of the size of surgery (85%) and its associated possible disadvantages (77%), the gap in evidence
on long term risks and benefits (43%), the lack of feasibility in certain patients and during vaginal surgery (66%).
Both patients (41%) and professionals (67%) identified the need for counselling material as facilitator.
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Conclusion: To reduce the variety in care regarding opportunistic salpingectomy, consensus and uniform
counselling is needed. Including the opportunistic salpingectomy in gynecological guidelines and a decision aid for
counselling could serve as tools to facilitate implementation.
Keywords: Salpingectomy, Primary prevention, Ovarian neoplasms, Risk reduction, Implementation science
Introduction
Ovarian cancer is the main cause of death among
patients diagnosed with a gynecological malignancy. The
vast majority of ovarian malignancies are epithelial ovar-
ian cancers (EOC), which have a poor five-year survival
rate [1]. This poor prognosis results from diagnosis in
an advanced stage of disease, often due to late onset of
symptoms and lack of early detection methods. Further-
more, comprehensive treatment swiftly results in recur-
rent disease, for which curative treatment options are
limited.
Interest in primary prevention of ovarian cancer has
increased following the identification of the Fallopian
tube as the main origin for the most common subtype of
EOC: high-grade serous ovarian carcinomas (HGSOC).
HGSOCs are thought to develop from Serous Tubal
Intra-Epithelial Carcinomas in Fallopian tube epithelium
[2–4]. Removal of the Fallopian tubes might therefore
lower HGSOC incidence, as shown in large cohort
studies where ovarian cancer incidence was reduced
following salpingectomy [5, 6]. The lifetime risk for
ovarian cancer of approximately 1.3% in the general
population does not warrant elective preventive surgery
in itself, as the risks of general anesthesia and surgery
outweigh the ovarian cancer risk [1]. However, ovarian
cancer risk could be reduced through opportunistic sal-
pingectomy (OS): the additional removal of Fallopian
tubes during pelvic surgery for another indication [5–8].
Although cohort studies show benefits, results from
randomized controlled trials regarding long term
outcomes are not expected for many years. Given the
opportunistic nature of OS, several international soci-
eties have issued guidelines which recommend to discuss
OS with all women undergoing abdominal surgery after
completion of childbearing [9]. These recommendations
emphasize the importance of counselling on benefits
and risks of OS but offer no guidance on their imple-
mentation in daily practice, which results in a wide vari-
ation in current practice among hospitals and individual
gynecologists [10]. This practice variation, often based
on the professionals’ preference instead of the patients’,
is undesirable.
To reduce practice variation, optimal implementation
of new recommendations concerning OS is essential.
Adaptation of daily practice is difficult and requires an
implementation strategy tailored to the needs of patients
and healthcare professionals, which is currently lacking.
According to the model of Change of Grol & Wensing,
the first step in the development of a tailored strategy is
to gain insight into factors influencing implementation
of OS from stakeholders’ perspectives [11]. In this study,
we aim to identify the barriers and facilitators in
implementing OS from both patients’ and professionals’
perspectives.
Material and methods
Study design and integration
We conducted a mixed-method study using the two-
phase Exploratory Sequential Design with a qualitative
following a quantitative phase [12]. In the qualitative
phase using a qualitative descriptive design [13], we
explored possible barriers and facilitators for the imple-
mentation of OS through individual in-depth telephone
interviews with patients and professionals, and one focus
group with gynecological residents. To assess the im-
portance in daily practice of the barriers and facilitators
found, cross-sectional questionnaires [14] were
developed for patients and professionals to quantify the
identified barriers and facilitators. For integration of the
data, we first analyzed the qualitative data for identifying
barriers and facilitators and then used these findings to
develop questionnaires for measuring its importance
(building) [12]. Figure 1 provides an overview of the
study design. This study was described following the
Good Reporting of a MM Study (GRAMMS) [15], the
consolidated criteria for reporting qualitative research
(COREQ) [16] (Additional file 1) and the Consensus-
Based Checklist for Reporting of Survey Studies
(CROSS) [17] (Additional file 2).
Qualitative phase
Patients
Patients were eligible for participation if they underwent
hysterectomy or sterilization in 2018 or 2019 and were
counselled on OS. Patients were purposively sampled
and approached for individual telephone interviews (to
lower the threshold for participation) by their treating
gynecologists from six hospitals (one university hospital
and five large teaching hospitals) throughout the
Netherlands to account for regional differences.
Professionals
Gynecologists with a special interest in endoscopy, on-
cology or urogynecology were approached for individual
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telephone interviews by one researcher (LvL). Gynecolo-
gists approached via the network of the Dutch Society of
Obstetrics and Gynecology (NVOG) were asked to par-
ticipate or suggest a colleague for participation. Profes-
sionals were approached by the researcher taking into
account dispersion throughout the Netherlands. Solely
gynecologists specialized in gynecological surgery were
recruited as they were expected to be most exposed to
OS. The gynecologists were employed in 12 hospitals
(one university, nine teaching and two non-teaching)
throughout the Netherlands to account for regional dif-
ferences. In addition, gynecological residents of the same
hospitals were given the opportunity to represent the
perspective of future gynecologists in a focus group that
was guided by a chairman (LvL). The participating resi-
dents represented different years of training.
Data collection
Separate semi-structured interview-guides were devel-
oped in advance by one researcher (LvL) based on
Fig. 1 Flowchart of study design. Footnote * the Dutch society for Obstetrics and Gynecology (NVOG) consists predominantly of gynecologists,
but contains some gynecological residents as well
Gelderblom et al. BMC Health Services Research          (2021) 21:736 Page 3 of 14
literature and experience within the research team, and
tested among two patients and two professionals. An ex-
pert in qualitative research (RH) and two gynecologists
(JP, JdH) evaluated and approved the interview-guides.
The two interviewers (MG, LvL) were medical doctors,
had experience in conducting qualitative research and
had no relationships with participants prior to the study.
Patients and professionals were questioned on their
knowledge and personal experience in the decision and
counselling of OS. To identify barriers and facilitators
on different domains classified according to the frame-
works of Grol & Wensing [18] and Flottorp [19], pa-
tients and professionals were questioned on: innovation
(OS), patient, healthcare professional, social context,
organization, and economic and political context.
Questions were open-ended, with optional questions to
deepen each domain. Interviews were conducted after
receiving written informed consent and verbal permis-
sion for audiotaping the interview. Data collection was
considered complete when data saturation was reached
and no new barriers and facilitators were identified for
two consecutive interviews. All interviews were audio-
taped after the interviewer introduced herself, commen-
ted on the research team, and described the study
purpose, procedure and funding. Introduction of the
study and person identifiable data were not audiotaped
for privacy reasons. Moreover, field notes were written
after each interview.
Data analysis
All interviews were transcribed verbatim, and two re-
searchers (MG, LvL) independently coded the transcripts
using ATLAS.ti (version 7.5.15, Atlas.ti Scientific
Software Development GmbH; Berlin, Germany). Tran-
scripts were not returned to participants for comments
or feedback. First, all interviews were fully read and
phrases were descriptively labelled by open coding. Sec-
ond, comparable descriptive codes were combined and
redefined into specific subthemes. The subthemes were
merged into the six broader domains of Grol & Wensing
[18] and Flottorp [19] using axial coding. After each step
findings were compared and disagreements were
discussed with a third researcher (RH) until consensus




All patients who underwent hysterectomy or sterilization
in 2018 and 2019 in two hospitals (one university
hospital and one large teaching hospital), were invited to
participate in a questionnaire by their treating
gynecologist. Patients were sampled using the purposive
sampling technique and represented women who were
eligible for OS. Therefore, patients were not selected for
age assuming that hysterectomy or sterilization was not
performed in case of uncompleted childbearing. Patients
were excluded from participation and completion of the
questionnaire if OS was not discussed during counsel-
ling. Written information was sent on behalf of their
gynecology department.
Professionals
Members of the NVOG with a special interest in endos-
copy, oncology and urogynecology were invited by email
to participate in a questionnaire. We used the purposive
sampling technique for sampling. Members were pre-
dominantly gynecologists, but included gynecological
residents as well.
Data collection
Based on the results of the interviews (qualitative phase),
two researchers (MG, RH) developed separate web-
based questionnaires for patients and professionals in
the online tool ‘LimeSurvey’ [20]. For convenience, the
patient questionnaire was also available on paper. Both
questionnaires started with a section on baseline charac-
teristics followed by statements on qualitatively identi-
fied barriers and facilitators that could be answered
according the 4-point Likert Scale (strongly disagree,
disagree, agree, and strongly agree). The option ‘not ap-
plicable’ was omitted to elicit an answer. The patient
questionnaire contained 28 questions and was pilot
tested by seven women, which was then adapted based
on their feedback. The professionals questionnaire con-
tained 46 questions and was pilot tested by two gynecol-
ogists and five gynecology residents as well. Initially all
questions were mandatory but as the questionnaire was
cut short if people felt unable to answer, all questions
were made optional and could be left blank. Participants
received information on the aim of the study and ques-
tionnaire. The patient invitation and questionnaire was
sent by mail or e-mail if the e-mail address was access-
ible. Patients who received the invitation by mail had the
choice to complete the questionnaire on paper or online
via an URL. The questionnaire for professionals was sent
by mass mail and accessible via an URL. Completing the
questionnaire took approximately 5–10min. All data
was processed anonymously and collected in an
electronic database using Castor EDC (Electronic Data
Capture) between January 2020 and June 2020.
Data analysis
Data was analyzed using SPSS (IBM Corp. Released
2016. IBM SPSS Statistics, version 24.0). Baseline charac-
teristics were descriptively analyzed and presented as
percentage or mean value. Descriptive statistics were
used to calculate the agreement with the statements.
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Responses reported were categorized in the scores
‘strongly disagree’, ‘disagree’, ‘agree’ and ‘strongly agree’.
In the text, ‘Disagree’ represented all ‘strongly disagree’
and ‘disagree’ responses amalgamated. ‘Agree’ represented
all ‘strongly agree’ and ‘agree’ responses amalgamated.
Internal consistency of the questionnaires was assessed
with Cronbach’s alpha per (sub) domain to estimate the
reliability [21]. All Cronbach’s alfa values were > 0.6, in-
dicating an acceptable level of reliability except for the
professionals’ subdomain ‘Patient: beliefs and knowledge’
(Additional file 3).
Results
An overview of the baseline characteristics of all
participants is provided in Table 1. A staged narrative
approach is used for reporting qualitative and quantita-
tive findings [12]. The qualitative data is discussed first,
an overview is provided in Table 2. Subsequently, the
barriers and facilitators most frequently identified in
quantitative analysis are discussed by domain.
Qualitative phase
Patients
Thirteen patients were approached for participation in
an individual interview. Participation was refused by two
patients since they did not respond to invitation.
Interviews were conducted with 11 patients between
June 2019 and February 2020. Six patients underwent a
hysterectomy and five a sterilization. Two patients made
the decision against OS. Interviews took 15 to 25 min
and were conducted by one of two researchers (MG,
LvL).
Professionals
All gynecologists who were approached to participate
participated. Individual interviews were conducted with
12 gynecologists between December 2019 and March
2019. Individual interviews took 15 to 40min. Gynecolo-
gists had mainly oncology as special interest and their
median work experience duration was 12 years.
Additionally, eight gynecological residents participated
in a focus group interview and took approximately 40
min.
Barriers and facilitators
Patients identified six barriers and eight facilitators in
only two domains; ‘innovation’ and ‘patient’. Profes-
sionals identified 26 barriers and 21 facilitators in all
domains (Table 1), ten of them were identified by both
patients and professionals. Figure 2 illustrates barriers
and facilitators in implementing OS identified in inter-
views by domain.
Several barriers and facilitators appeared consistently
throughout all interviews. As a result, they were clear
based on the qualitative data. We refrained from verifi-
cation through questionnaires to limit the length of the
questionnaire. In the domain innovation this concerned:
the low life time risk of ovarian cancer in the general
population and the residual risk after OS as barriers,
mentioned by both patients and professionals. The re-
duction of ovarian cancer risk combined with the high
lethality of this disease, the loss of tubal function after
completion of childbearing, and family history of ovarian
cancer were appointed as facilitators.
Quantitative phase
Patients
The questionnaire was sent to 287 patients and yielded a
response rate of 37% (n = 106); 27 patients were
excluded as they were not counselled on OS, and two
patients did not complete the questionnaire. Responses
of 77 patients were included for analysis. Patients repre-
sented different educational levels and had a mean age
of 43 years (SD 6.5). Furthermore, 69 patients made the
decision for or against OS themselves, 55 of which
choose for OS.
Professionals
The questionnaire was sent to approximately 600 mem-
bers of the NVOG with special interest in endoscopy,
oncology and urogynecology and yielded a response rate
of 34%. All 204 responses were included for analysis:
94% of the respondents were gynecologists, 56% was
employed in a teaching hospital. Both gynecologists and
residents had mainly benign and/or endoscopy as special
interest. The median work experience duration among
gynecologists was 10 years (IQR 5–17).
Barriers and facilitators
The patients’ questionnaire contained eight barrier and
nine facilitator statements exclusively in the subdomain
‘patient’ (Fig. 3). The professionals’ questionnaire
contained 24 barrier and 18 facilitator statements in all
domains (Fig. 4).
Innovation (OS) Professionals indicated that OS cannot
be performed in all cases without additional risks due to
adhesions and vaginal approach (66%), and the insuffi-
cient evidence on the long-term effects such as age at
onset of menopause (43%) as barriers. Almost all profes-
sionals (99%) mentioned the high success rate of OS as
facilitator for the laparoscopic/laparotomic approach.
Patient Patients mentioned three barriers related to pa-
tients’ knowledge: 1. lack of knowledge on the possible
disadvantages of OS (37%); 2. no insight in the size of
the surgery (44%), in which size refers to the potential
complications and health impact associated; 3. and never
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Duration interviews in minutes (mean – SD) 19.8 (± 4.2) –
Age (mean – SD) 42.1 (± 7.2) 43.0 (± 6.5)
Level of education
Primary / pre-vocational school 0 8 (10%)
Vocational education 3 26 (34%)
Pre-college education / college 1 30 (39%)
University 0 12 (16%)
Missing 7 1 (1%)
Type of surgery
Hysterectomy 6 59 (77%)
Sterilization 5 18 (23%)
Menopausal state
Premenopausal 10 60 (78%)
Menopausal 0 14 (18%)
Post-menopausal 1 2 (2%)
Missing 0 2 (2%)
Family history of ovarian cancer
First-degree relative 1 2 (3%)
Second-degree relative 2 3 (4%)
None 1 70 (91%)
Unknown / missing 7 2 (3%)
Made the decision on whether or not to undergo OS herself
Yes, patient chose for OS 7 55 (71%)
Yes, patient chose against OS 2 14 (18%)
No, clinician made the decision 2 6 (8%)
Other 0 2 (3%)
Counselled by gynecologist 11 74 (96%)
Missing 0 3 (4%)
Satisfied with the decision
Yes 9 70 (91%)
No 0 3 (4%)





Gynecologists 12 (60%) 195 (94%)
Duration interviews in minutes (mean – SD) 24.9 (± 7.3) –
Age (mean – SD) 47.4 (± 7.3) 46.8 (± 7.8)
Work experiences in years 12 (IQR 7–16) 10 (IQR 5–17)
Gender
Female 9 132 (68%)*
Male 3 63 (32%)*
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heard of the possibility of OS prior to consultation
(45%). The first two barriers were identified as barrier by
professionals as well (85 and 77% respectively). Regard-
ing patients’ motivation, 46% of patients attributed their
reluctance to concerns about removing healthy organs if
this was not required. Moreover, patients would be
concerned if OS could not be performed during surgery
because of an increased risk of complications (52%). In
contrast, professionals (63%) indicated that patients were
often unconcerned if OS could not be performed.
Regarding facilitators, 40% of the patients mentioned
the need for counselling material complementary to
consultation with their gynecologist, in particular for a
patient decision aid (PtDA) about OS during abdominal
surgery (43%) and the various sterilization methods in-
cluding OS (72%).
Health care professional Professionals mentioned one
barrier concerning insufficient skills to perform OS by
vaginal approach (53%) and six facilitators related to
their needs and preferences such as additional counselling
material about OS (67%). A PtDA about OS as addition to
abdominal surgery (51%) and the various sterilization
methods including OS (78%) could facilitate counselling.
Furthermore, professionals indicated they would counsel
for OS more often if they had access to counselling mater-
ial (49%), and if more evidence existed about its effective-
ness with regards to risk reduction (45%) and long-term
effects of OS such as the onset of menopause (53%).
Organizational context Professionals mentioned the
need for more surgery time (38%), and an increase of
the consultation duration (36%) as barriers. Of the pro-
fessionals, 80% reported that all Fallopian tubes should
be submitted for pathological analysis.
Social context According to 99% of the professionals, a
clear policy on OS within the individual gynecology de-
partments would contribute to implementation of OS.
To ensure complete implementation of OS national
Table 1 Baseline demographics of patients and professionals in interviews and questionnaires (Continued)
Interviews Questionnaires
Special interest1
Benign and/or endoscopy 2 130 (67%)*
Oncology 11 83 (43%)*
Urogynecology 7 57 (29%)*
Other 0 6 (3%)*
Type of hospital2
Academic 1 40 (21%)*
Teaching hospital 9 110 (57%)*
Non-teaching hospital 2 50 (26%)*
Gynecological residents 8 9 (4%)
Duration interviews in minutes (mean) 40 –





1 or 2 1 0
3 or 4 5 0
5 or 6 2 9
Special interest1




*Percentage of gynecologist or gynecological residents subgroup; 1 Gynecologists and gynecological residents might have multiple special interests; 2 Some
gynecologists were employed in multiple hospitals
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consensus would be necessary (92%). Including OS in
the guidelines of the NVOG (99%) would facilitate the
implementation.
Economic and political context Professionals men-
tioned not knowing how OS should be invoiced (72%)
and which diagnosis treatment combination contains OS
(72%) as barriers.
Discussion
In this mixed-method study, we identified influencing
factors for the implementation of OS from patients’ and
professionals’ perspective through semi-structured inter-
views and questionnaires. In interviews, patients indi-
cated solely barriers and facilitators in the innovation
and patient domain. Professionals indicated barriers and
facilitators in all domains. Both stakeholders consistently
Table 2 Barriers and facilitators identified during interviews and focus group by patients and professionals
Domain Barriers Facilitators
Identified by patients
Innovation (OS) • Low life time risk of ovarian cancer in general population
• Insufficient evidence of long-term risks and effects
• Reduction of ovarian cancer risk
• Family history of ovarian cancer
• Fallopian tubes lose function after completion of childbearing
• High lethality rate of ovarian cancer
Patient • Unwillingness to have healthy organs removed
• Lack of insight into the size of surgery
• Worry if OS fails
• Complicated choice whether or not to undergo OS
• Reliable information material such as a decision aid
• Counselled and advised by their gynecologists
• Confidence in treating physician
• A small additional scar in case of sterilization is not a problem
Identified by professionals
Innovation (OS) • Low life time risk of ovarian cancer in general population
• Presence of residual risk of ovarian cancer after OS
• Risk of overtreatment
• Insufficient evidence of long-term risks and effects
• Complicating the surgery, especially in patients with
certain medical history
• More difficult during vaginal surgery
• More extensive surgery as sterilization method
• Unclear limits of the eligible population
• Reduction of ovarian cancer risk
• High lethality rate of ovarian cancer
• High success rate for OS
• No increase in complication risk compared to complication risk of
the primary procedure
• No extension of surgery in case of a hysterectomy
• Fallopian tubes lose function after completion of childbearing
• Family history of ovarian cancer
Health care
professional
• Unaware or not convinced of evidence
• Insufficient skills to perform OS
• Experiencing time pressure during consultation due to
counselling for OS
• Forgetting to counsel about OS
• Uniform counselling material such as a decision aid
• Performing a national prospective follow up study for OS
registration and ovarian cancer
Patient • Unwillingness to have healthy organs removed
• Unwillingness to take unnecessary risks
• Fear of earlier menopause
• Lack of knowledge concerning the disadvantages
• Lack of insight into the size of surgery
• Lack of knowledge concerning the difference between
ovaria and fallopian tubes
• Complicated choice
• High acceptance among patients
• High awareness of OS
• Not worrying if performing OS fails
Organization • Limited time to provide counselling
• Increased surgical time, especially for sterilization
• More time and pathologists needed for analysis of the
Fallopian tubes
• Additional (telephone) consultation required
• Counselling for OS possible during regular consultation
• No additional surgical instruments are required
Social • National consensus on OS
• Communal policy about OS in gynecological department
• Inclusion of OS in the guidelines of the Dutch society for
Obstetrics and Gynecology (NVOG)
• Inclusion of OS in the guideline of the Dutch College of General
Practitioners (NHG)
• Inclusion of the recommendation to discuss OS in several
guidelines of international societies
Economic and
Financial
• Higher costs due to Fallopian tube analysis by
pathologists
• Higher costs due to increase in surgical time in case of
sterilization
• Invoicing of OS is unclear
• Cost-effectiveness on long term due to opportunistic nature
• No extra costs in case of additional intervention
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mentioned the overall low ovarian cancer risk and re-
sidual cancer risk after OS as main barriers. Cancer risk
reduction and high lethality of ovarian cancer were main
facilitators together with the loss of tubal function after
completion of childbearing and family history of ovarian
cancer. Subsequently, questionnaires determined the im-
portance of barriers and facilitators found. Among other
things, both stakeholders indicated patients lack of
knowledge about OS as barrier, and the availability of
adequate counselling material as facilitator.
From a patients’ perspective, the most important barrier
in deciding whether or not to undergo OS is that they are
simply unaware of its existence. Patients also lack know-
ledge on the advantages, disadvantages and the magnitude
of the intervention, which prevents a well-informed deci-
sion. Adequate information on all aspects of the surgery is
essential to enable patient participation in decision making
[22]. The content should be based on the patients’
knowledge needs and fully explain all aspects that could
potentially influence the decision for patients.
Fig. 2 Illustrative quotations from patients and professionals concerning barriers and facilitators on implementation of OS
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Whether or not patients want to undergo OS depends
on their personal beliefs and values. Although healthcare
professionals often feel they know what is important for
patients, this may not always be true [23]. Our findings
show discrepancies between patients’ and professionals’
responses on the domain of patient emotions and motiv-
ation, for example on patients’ concerns following a
failed OS or that some patients are reluctant about the
removal of healthy organs if this is not strictly necessary.
Uniform counselling material could counteract the
current practice variation caused by professionals’ prefer-
ences in patient counselling, especially due to the prefer-
ence sensitive nature of this decision [24]. Incorporating
the counselling (material) of OS in gynecological guide-
lines subsequently creates consensus [25].
An important barrier for professionals is the gap in
evidence on the long-term effects of OS, especially re-
garding the onset of menopause. OS could potentially
accelerate onset of menopause through a reduction of
the blood supply to the ovaries and a subsequent dimin-
ished ovarian reserve. Earlier menopause could affect
sexual wellbeing, quality of life and increased cardiovas-
cular disease risk [26, 27]. Although short-term follow-
up studies do not show a decreased ovarian reserve due
to OS in women who underwent hysterectomy, a recent
review [28] indicates a possible effect consistent with an
earlier onset of menopause with a maximum of 20
months. In spite of the probability that clear evidence on
long term effects will take several more decades, the
popularity of OS is increasing. Therefore, until more
evidence is obtained from currently ongoing trials such
as HOPPSA (ClinicalTrials.gov;NCT03045965, [29]) and
STOPOVCA-young (ClinicalTrials.gov;NCT04757922), it
is crucial to inform patients that OS may lead to a slightly
earlier onset of menopause.
Professionals questioned the feasibility of OS in
patients with adhesions. Since these patients have an in-
creased risk of complications during abdominal surgery,
it raises the question whether the benefits continue to
outweigh the risks. The same applies to OS during vagi-
nal surgery; professionals indicate they may lack the
skills to perform OS via the vaginal route. These findings
are likely to be related to the inaccessibility of the
Fallopian tubes and less experience with the vaginal
approach. However, the vaginal approach should not be
a contraindication to OS since professionals report a
high success rate [30]. Moreover, a vaginal approach is
often preferable as these patients return to normal activ-
ities more quickly [31]. Professional should remain
aware of the opportunistic and preventive nature of OS
and should refrain from performing OS if the benefits
do not outweigh the risk. Informing patients of this
caveat will provide reassurance if the intention of OS
cannot be fulfilled.
The main organizational barrier to implement OS is
the additional time it takes in several aspects of daily
practice, particularly: 1. additional surgical time due to
OS, which reflect the findings of McAlpine et al., 2016
[32], and Jones et al., 2017 [33]; 2. the need for add-
itional counselling time to discuss OS, leading to longer
consultations; 3. additional routine examination of the
Fallopian tubes requires time of the pathologist. This
touches on the barriers found on the financial level, indi-
cating the uncertainties about invoicing of OS, since OS
is performed in addition to an already planned surgery.
A short-term solution is required through national
Fig. 3 Patients’ responses to statements regarding barriers and facilitator towards implementation of OS by domain
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Fig. 4 Professionals’ responses to statements regarding barriers and facilitator towards implementation of OS by domain
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regulations regarding billing. Although OS may incur
additional health care costs in the short-term, long-term
health care costs concerning ovarian cancer will decline
as OS will reduce the number of cancer cases [34, 35].
Our study shows a variation in current practice re-
garding OS by the proportion of patients who were not
counselled and did not receive any information about
OS. This is in contrary with the international guidelines
that recommend discussion of OS with all women
undergoing gynecological abdominal surgery after com-
pletion of childbearing. To reduce this variation, the up-
take of OS by professionals might be promoted through
exposure of the recommendations from multiple sources
[36]. Both our findings and the study by Jones et al.,
2017 [33] suggest a source like a guideline outlining the
safety, potential benefits and risks of OS. Moreover, the
mentioned barriers on lack of knowledge and counsel-
ling can be assuaged by the development of a PtDA,
according to the criteria of the International Patient
Decision Aid Standards Collaboration [37]. In this
counselling tool, the decision regarding OS needs to be
deliberated on complete information of (potential) disad-
vantages and benefits. In this way a PtDA about OS
could ease both stakeholders needs for counselling ma-
terial, improve patients’ knowledge, assist counselling by
professionals and function as source.
The main strength of our study was that we used
mixed-methods to identify possible influencing factors
from the perspective of both patients and professionals.
The in-depth interviews of phase 1 explored a wide
range of detailed barriers and facilitators, while the ques-
tionnaires of phase 2 provided insight into whether these
barriers and facilitators were more personal or if they
were supported by a majority of the group. We used the
theoretical frameworks of Grol&Wensing and Flottorp
for exploration of both barriers and facilitators influen-
cing implementation of OS. Clearly, there are limitations
of the present study. First, the use of these frameworks
could be argued since patients indicated influencing fac-
tors in solely two domains, while factors that facilitate or
hinder implementation in clinical practice might affect
various domains. However, our findings suggest that this
is not applicable to patients in the implementation of
OS. It could conceivably be hypothesized that the minor
addition of OS not noticeably affects the care process for
patients. Secondly, the inclusion of solely professionals
experienced with gynecological surgery and the
skewedness towards the special interest oncology might
bias the existing barriers and facilitators in the entire
gynecological field. For example, obstetricians who are
less likely to perform an OS, might have other insights
because of their less experience in adnexal surgery.
Generalizability of our finding can therefore be question-
able. Finally, some statements were identified as both a
barrier and a facilitator during the interviews. To pre-
vent participants from feeling that they had to answer
the same question twice, we included a statement as a
barrier if the statement was more often referred to as a
barrier during the interviews and vice versa. However, if
this statement was not confirmed as barrier during the
quantitative phase it remained unclear if it would have
been a facilitator instead.
Conclusion
We identified barriers and facilitators affecting the imple-
mentation of OS. To reduce the variety in care regarding
OS, consensus among gynecologists on the indication for
OS and the content of uniform counselling seems needed.
Gynecological guidelines and a PtDA could serve as
implementation tools for both stakeholders.
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